Lupin share price fell 1.5% on Wednesday’s early following Q4FY23 results. The pharma major on Tuesday, reported a consolidated net profit of ₹246.7 crore in the fourth quarter of FY23, which is attributable to the owners of the company. Lupin shares opened at intraday high of ₹750 per share on NSE.
The most recent PAT compares to a net loss of ₹344.27 crore in the fourth quarter of FY22. On an annual basis, the company experiences revenue growth in the double digits. Lupin’s Q4 PAT did, however, decline by 25.3% compared to the December 2022 quarter’s net profit of ₹330.43 crore.
Know your inner investor
Do you have the nerves of steel or do you get insomniac over your investments? Let’s define your investment approach.
Download The Mint News App to get Daily Market Updates.